Oslo, 14 October 2025: As part of NEXT Biometrics Group ASA's ("NEXT" or the "Company") long-term incentive program set out in the Company's guidelines for remuneration of senior executives, the below primary insiders of the Company have been granted share options:
-Ulf Ritsvall (CEO) has been granted 1,000,000 share options in the Company, following which he holds a total of 5,125,000 share options.
-Marcus Lauren (Chief Product Officer) has been granted 500,000 share options in the Company, following which he holds a total of 725,000 share options.
-Joshua Chi (Senior Vice President, Head of Sales South-East Asia) has been granted 150,000 share options in the Company, following which he holds a total of 425,000 share options.
-DigVijay Singh Kanwar (Senior Vice President, Head of Sales IUEA) has been granted 300,000 share options in the Company, following which he holds a total of 650,000 share options.
With regards to the 2025 option program for management and key employees, in total 33% of the options vest in the third calendar quarter of 2026, 33% of the options vest in the third calendar quarter of 2027 and the remaining 33% vest in the first calendar quarter of 2028. The date of expiry for all vested options is 9 May 2030. Any options that are not exercised at, or prior to this date will elapse. The exercise price of the share options for management and key employees shall be equal to the average volume weighted market price of the Company's shares over the last five trading days prior to the date of grant, being NOK 3.38.
Reference is further made to the stock exchange announcement by the Company on 8 October 2025 regarding the resolution by the extraordinary general meeting to grant Roy Tselentis (deputy chair of the Company's board of directors) a total of 300,000 share options in the Company, following which he holds a total of 500,000 share options.
Of the 300,000 share options granted to Roy Tselentis, 150,000 of the share options shall have an exercise price of NOK 4.25, while the exercise price for the remaining 150,000 of the share options shall be NOK 5.00.
With regards to the 2025 option program for board members, in total 50% of the options will vest on 9 May 2026 and 50% of the options will vest on 9 May 2027. The date of expiry for all vested options is 9 May 2030. Any options that are not exercised at, or prior to this date will elapse.
After the above-mentioned allotments, if all conditions are met, the total number of issued share options in the Company is 14,341,825.
Please see the attached forms for further information.
This information is subject to the disclosure requirements pursuant to Article 19 of the EU Market Abuse Regulation and section 5-12 of the Norwegian Securities Trading Act.
For further information, please contact:
Ulf Ritsvall, CEO
Email: ulf.ritsvall@nextbiometrics.com
Eirik Underthun, CFO
Email: eirik.underthun@nextbiometrics.com
About NEXT Biometrics:
NEXT Biometrics is a pioneer of high-security biometric authentication, enabling users to live simpler, safer lives. NEXT Biometrics was founded on the belief that strong authentication and identification can be secure, seamless and cost effective for governments and businesses with Active Thermal® technology. More than 25 years later, NEXT has retained its Norwegian heritage and grown to serve customers globally.
Today, our solutions are used by billions of users each year across 10+ national ID and local programs, 150.000+ POS terminals, 25+ laptop and tablet models from tier-1 OEMs, and physical and logical access control implementations. Through state-of-the-art technology, deep industry expertise and close collaboration with partners for seamless integration, Active Thermal® biometrics can make life simpler and safer for everyone.
For more information, visit NEXT Biometrics, read our blog and follow us on LinkedIn. NEXT Biometrics is listed on Euronext (NEXT.OL).